ICD-10-CM Billable Code

C79.2

Secondary malignant neoplasm of skin

Clinical Classification Guidelines

Excludes Type 1

  • secondary Merkel cell carcinoma (C7B.1)

Medical Intelligence & Overview

Secondary malignant neoplasm of the skin, classified under ICD-10 code C79.2, refers to the spread of cancer cells from a primary source elsewhere in the body to the skin. This condition indicates that the skin is affected not as the original site of cancer, but as an area where malignant cells have metastasized. Such secondary skin tumors are manifestations of advanced malignancies and often require comprehensive medical management. Recognizing the signs and understanding the implications of this diagnosis can be essential for patients and their healthcare providers in planning appropriate care.

Causes & Symptoms

Clinical Causes: Metastasis from primary cancers such as breast, lung, colon, melanoma, or other internal malignancies. Spread of malignant cells through the bloodstream or lymphatic system. Progression of an existing primary cancer to involve the skin tissue. Incomplete removal or treatment of primary cancer, leading to spread. Sometimes, unknown primary origin, where the primary tumor is not identified.

Key Symptoms: Appearance of skin nodules or lumps which may be firm or tender. Presence of skin ulcers or sores that do not heal. Changes in skin color or texture in localized areas. Pain or discomfort in the affected area. Rapid growth of skin lesions compared to benign moles or spots. Possible itching or bleeding from the lesion. Multiple skin lesions in different areas indicating widespread metastasis.

Diagnostic & Treatment

Diagnosis Path: Diagnosis of secondary malignant neoplasm of the skin involves a combination of clinical examination, imaging studies, and tissue analysis. Key steps include: - Physical examination of skin lesions. - Biopsy of the suspicious skin lesion to confirm malignant cells. - Imaging techniques such as CT scans, PET scans, or MRI to identify primary tumors and assess spread. - Laboratory tests to evaluate overall health and organ function. - Review of medical history, including previous cancers or treatments. The biopsy is critical as it distinguishes metastatic skin lesions from primary skin cancers or benign conditions.

Treatment Protocols: Managing secondary malignant neoplasm of the skin depends on the extent of metastasis, type of primary cancer, and overall health of the patient. Treatment options include: - Systemic therapies such as chemotherapy, targeted therapy, or immunotherapy aimed at controlling primary and secondary tumors. - Local treatments like surgical excision or radiation therapy for symptomatic skin lesions. - Supportive care to alleviate symptoms and improve quality of life. - Multidisciplinary approach involving oncologists, dermatologists, and surgeons. - Palliative treatments may be considered in cases where curative options are limited. It’s important to work closely with healthcare professionals to determine the most appropriate approach based on individual circumstances.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C79.2 a billable ICD-10 code?
Yes, C79.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C79.2?
Clinical documentation must specify the nature of Secondary malignant neoplasm of skin and any associated comorbidities for accurate reporting.

Cite this Clinical Reference